DOCS logo

Doximity, Inc. (DOCS) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Doximity, Inc. (DOCS), Healthcare sektöründe faaliyet gösteriyor, son olarak 23.69$'dan işlem görüyor ve 5B piyasa değerine sahip. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 52/100 puan alıyor.

Son analiz: 8 Şub 2026
52/100 AI Puanı Hedef $46.16 (+94.9%) PD 5B Hacim 2M

Doximity, Inc. (DOCS) Sağlık ve Boru Hattı Genel Bakışı

CEOJeffrey A. Tangney
Çalışanlar827
MerkezSan Francisco, CA, US
Halka Arz Yılı2021
SektörHealthcare

Doximity is revolutionizing healthcare communication with its cloud-based platform, connecting medical professionals for enhanced collaboration, patient care, and career development, while boasting impressive financials like a 37.5% profit margin and 89.7% gross margin, making it a compelling investment in the digital health space.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

Doximity presents a notable research candidate due to its dominant position in the medical professional networking space and its high-margin business model. The company's platform is deeply embedded in the daily workflows of physicians, creating a strong network effect and high barriers to entry. With a market capitalization of $5.21 billion and a P/E ratio of 21.72, Doximity demonstrates financial strength and growth potential. Key value drivers include continued expansion of its user base, increased adoption of its telehealth and advertising solutions, and strategic partnerships with healthcare systems and pharmaceutical companies. The company's impressive gross margin of 89.7% and profit margin of 37.5% highlight its operational efficiency and pricing power. Upcoming catalysts include the further integration of AI-powered tools into the platform and expansion into new medical specialties, solidifying its position as a leader in healthcare technology.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $5.21 billion, reflecting strong investor confidence in Doximity's market position and growth prospects.
  • P/E ratio of 21.72, indicating a premium valuation based on its earnings potential and growth trajectory.
  • High gross margin of 89.7%, showcasing the company's efficient cost structure and pricing power in the healthcare technology market.
  • Profit margin of 37.5%, demonstrating strong profitability and effective management of operating expenses.
  • Beta of 1.39, suggesting higher volatility compared to the market, potentially offering greater returns but also increased risk.

Rakipler & Benzerleri

Güçlü Yönler

  • Dominant position in the medical professional networking space.
  • High gross and profit margins.
  • Strong network effect and user engagement.
  • Comprehensive platform with a wide range of features.

Zayıflıklar

  • Reliance on advertising revenue, which can be cyclical.
  • Limited geographic diversification, primarily focused on the United States.
  • Potential for increased competition from larger technology companies.
  • Vulnerable to changes in healthcare regulations and policies.

Katalizörler

  • Ongoing: Continued expansion of telehealth services driving increased user engagement and revenue.
  • Upcoming: Integration of AI-powered tools to enhance platform functionality and improve user experience.
  • Ongoing: Strategic partnerships with healthcare systems to expand reach and market penetration.
  • Upcoming: Launch of new features and services tailored to specific medical specialties.

Riskler

  • Potential: Increased competition from larger technology companies entering the healthcare market.
  • Potential: Data security and privacy breaches compromising user data and damaging reputation.
  • Ongoing: Changes in healthcare regulations and reimbursement policies impacting revenue streams.
  • Potential: Economic downturn leading to reduced advertising spending from pharmaceutical manufacturers.

Büyüme Fırsatları

  • Expansion of Telehealth Services: Doximity has the opportunity to further expand its telehealth offerings, capitalizing on the increasing demand for virtual patient visits. The telehealth market is projected to reach $285.7 billion by 2027, presenting a significant growth opportunity for Doximity. By enhancing its virtual visit platform and integrating it with other clinical workflows, Doximity can attract more physicians and patients, driving revenue growth and solidifying its position in the telehealth market.
  • Increased Adoption of Advertising Solutions: Doximity can leverage its extensive network of medical professionals to drive increased adoption of its advertising solutions among pharmaceutical manufacturers and healthcare systems. The digital health advertising market is estimated to be worth billions of dollars annually. By offering targeted advertising campaigns and demonstrating the effectiveness of its platform in reaching physicians, Doximity can capture a larger share of this market and generate substantial revenue growth.
  • Strategic Partnerships with Healthcare Systems: Doximity can forge strategic partnerships with healthcare systems to integrate its platform into their existing workflows and electronic health record systems. These partnerships can provide Doximity with access to a larger pool of physicians and patients, driving user growth and increasing platform engagement. By collaborating with healthcare systems, Doximity can also develop customized solutions that address their specific needs, further strengthening its competitive advantage.
  • Integration of AI-Powered Tools: Doximity can integrate AI-powered tools into its platform to enhance its functionality and improve the user experience. AI can be used to automate tasks, personalize content, and provide insights to physicians, making the platform more valuable and engaging. By leveraging AI, Doximity can differentiate itself from competitors and attract more users, driving revenue growth and solidifying its position as a leader in healthcare technology.
  • Expansion into New Medical Specialties: Doximity can expand its platform to include new medical specialties, broadening its reach and increasing its user base. By tailoring its platform to the specific needs of different specialties, Doximity can attract more physicians and generate additional revenue streams. This expansion can be achieved through targeted marketing campaigns, partnerships with medical associations, and the development of specialty-specific content and tools.

Fırsatlar

  • Expansion into new medical specialties and geographic markets.
  • Increased adoption of telehealth and virtual care solutions.
  • Strategic partnerships with healthcare systems and pharmaceutical companies.
  • Integration of AI-powered tools to enhance platform functionality.

Tehditler

  • Increased competition from existing and new players in the healthcare technology market.
  • Data security and privacy breaches.
  • Changes in healthcare regulations and reimbursement policies.
  • Economic downturn impacting advertising spending.

Rekabet Avantajları

  • Strong network effect due to its large and engaged user base of medical professionals.
  • High switching costs for users who have integrated the platform into their daily workflows.
  • Proprietary technology and data analytics capabilities.
  • Established brand reputation and trust within the medical community.

DOCS Hakkında

Doximity, Inc., initially founded as 3MD Communications, Inc. before rebranding in June 2010, emerged in 2010 with a vision to transform how medical professionals connect and collaborate. Headquartered in San Francisco, Doximity has established itself as a leading cloud-based digital platform tailored for the specific needs of physicians and healthcare providers across the United States. The platform offers a suite of tools designed to streamline workflows, enhance communication, and facilitate continuous learning. Doximity's core offerings include secure messaging for HIPAA-compliant communication, a virtual patient visit platform for telehealth consultations, and a comprehensive medical news feed to keep members updated on the latest research and clinical advancements. Furthermore, the platform provides career management resources, enabling physicians to explore job opportunities and advance their professional development. Doximity primarily serves pharmaceutical manufacturers and healthcare systems, offering targeted advertising and marketing solutions through its extensive network of medical professionals. With 827 employees, Doximity continues to innovate and expand its platform to meet the evolving needs of the healthcare industry.

Ne Yaparlar

  • Provides a cloud-based digital platform for medical professionals.
  • Enables collaboration among physicians and healthcare providers.
  • Facilitates coordination of patient care through secure messaging and virtual visits.
  • Offers a virtual patient visit platform for telehealth consultations.
  • Delivers up-to-date medical news and research to its members.
  • Provides career management resources for physicians.
  • Connects pharmaceutical manufacturers and healthcare systems with medical professionals for targeted advertising.

İş Modeli

  • Subscription fees from healthcare systems for access to the platform and its features.
  • Advertising revenue from pharmaceutical manufacturers targeting physicians.
  • Revenue from virtual patient visit platform usage.
  • Data analytics and insights services for healthcare organizations.

Sektör Bağlamı

Doximity operates within the rapidly growing healthcare information services industry, driven by the increasing adoption of digital health technologies and the need for improved communication and collaboration among healthcare professionals. The market is characterized by intense competition, with companies vying for market share in telehealth, electronic health records, and medical networking. Doximity's focus on providing a comprehensive platform specifically tailored for physicians gives it a competitive edge. The industry is expected to continue its growth trajectory, fueled by factors such as the aging population, rising healthcare costs, and advancements in technology.

Kilit Müşteriler

  • Physicians and other medical professionals.
  • Pharmaceutical manufacturers.
  • Healthcare systems.
  • Medical associations.
AI Güveni: 74% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

Doximity, Inc. (DOCS) hisse senedi fiyatı: $23.69 (-0.62, -2.55%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

DOCS için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

Konsensüs hedefi: $46.16

MoonshotScore

52/100

Bu puan ne anlama geliyor?

MoonshotScore, DOCS'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Doximity, Inc. Hissesi: Cevaplanan Temel Sorular

DOCS için değerlendirilmesi gereken temel faktörler nelerdir?

Doximity, Inc. (DOCS) şu anda yapay zeka skoru 52/100, orta puanı gösteriyor. Hisse 18.6x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) altında, potansiyel değer sinyali. Analist hedefi $46.16 ($23.69'dan +95%). Temel güçlü yan: Dominant position in the medical professional networking space.. İzlenmesi gereken birincil risk: Potential: Increased competition from larger technology companies entering the healthcare market.. Bu bir finansal tavsiye değildir.

DOCS MoonshotScore'u nedir?

DOCS şu anda MoonshotScore'da 52/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

DOCS verileri ne sıklıkla güncellenir?

DOCS fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler DOCS hakkında ne diyor?

Analistler, DOCS için $46.16 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($23.69) yukarı yönlü %95 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.

DOCS'a yatırım yapmanın riskleri nelerdir?

DOCS için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Increased competition from larger technology companies entering the healthcare market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

DOCS'ın P/E oranı nedir?

Doximity, Inc. (DOCS)'nın son P/E oranı 18.6, ki bu da piyasa ortalamasının altında, bu da göreli değeri gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.

DOCS aşırı değerli mi, yoksa düşük değerli mi?

Doximity, Inc. (DOCS)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 18.6. Analist hedefi $46.16 (mevcut fiyattan +95%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

DOCS'ın temettü verimi nedir?

Doximity, Inc. (DOCS) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is based on available data as of 2026-02-08. Market conditions and company performance may change over time.
Veri Kaynakları

Popüler Hisseler